SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-009422
Filing Date
2022-02-25
Accepted
2022-02-25 14:55:52
Documents
2
Period of Report
2022-02-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3930
2 POWER OF ATTORNEY ea156180ex24-1_adialpharma.htm EX-24.1 7150
  Complete submission text file 0001213900-22-009422.txt   12667
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address
Gilliland Robertson H. (Reporting) CIK: 0001718351 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38323 | Film No.: 22678840